EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Open Access

18 F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation

Jennifer Holter-Chakrabarty iD, Lacey McNally, John Levine, James Ferrara, Sara K Vesely iD, Christopher G Kanakry, Tabitha Garwe, Zheng Han iD, Manu Pandey, Joshua Glover iD, Yuejin Wen, Ron Gress und 1 weitere

Radiology: Imaging Cancer · 2025

DOI: 10.1148/rycan.240096 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Radiology: Imaging Cancer, 2025. Verfasst von Jennifer Holter-Chakrabarty und 12 weiteren Autor:innen. Beteiligte Einrichtung: From the Stephenson Cancer Center, University of Oklahoma Health Sciences Center, 800 NE 10th St, Oklahoma City, OK 73104 (J.H.C., L.M., S.K.V., Z.H.…. Hauptthemen laut MEDLINE: Biomarkers, Dideoxynucleosides, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, CCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flourine 18 fluorothymidine PET has the potential to be a valuable tool in the identification of clinical and subclinical gastrointestinal graft versus host disease (GI-GVHD) and, if validated, could serve as an imaging biomarker for GI-GVHD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersDideoxynucleosidesGraft vs Host DiseaseHematopoietic Stem Cell TransplantationPositron-Emission TomographyAdultFemaleHumansMaleGastrointestinal DiseasesPilot ProjectsProspective StudiesRadiopharmaceuticalsTransplantation, Homologous

Stichwörter der Autor:innen

Abdomen/GIBone MarrowPET/CTTransplantation

Substanzen

alovudineBiomarkersDideoxynucleosidesRadiopharmaceuticals

Autor:innen und Institutionen

  • From the Stephenson Cancer Center, University of Oklahoma Health Sciences Center, 800 NE 10th St, Oklahoma City, OK 73104 (J.H.C., L.M., S.K.V., Z.H., M.P., J.G., Y.W.); Tisch Cancer Institute, Icahn School of Medicine…

ORCID-Profile: Jennifer Holter-Chakrabarty, Sara K Vesely, Zheng Han, Joshua Glover

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS
  • CCR NIH HHS
  • National Cancer Institute
  • National Institutes of Health
  • Department of Health and Human Services
  • National Heart, Lung, & Blood Institute
  • Oklahoma Tobacco Settlement Endowment Trust

Zitieren

APA

Holter-Chakrabarty, J., McNally, L., Levine, J., Ferrara, J., Vesely, S. K., Kanakry, C. G., Garwe, T., Han, Z., Pandey, M., Glover, J., Wen, Y., Gress, R., & Williams, K. M. (2025). 18 F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation. Radiology: Imaging Cancer. https://doi.org/10.1148/rycan.240096

Vancouver

Holter-Chakrabarty J, McNally L, Levine J, Ferrara J, Vesely SK, Kanakry CG, et al. 18 F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation. Radiology: Imaging Cancer. 2025. doi:10.1148/rycan.240096

BibTeX
@article{HolterChakrabarty2025,
  author = {Holter-Chakrabarty, Jennifer and McNally, Lacey and Levine, John and Ferrara, James and Vesely, Sara K and Kanakry, Christopher G and Garwe, Tabitha and Han, Zheng and Pandey, Manu and Glover, Joshua and Wen, Yuejin and Gress, Ron and Williams, Kirsten M},
  title = {18 F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation},
  journal = {Radiology: Imaging Cancer},
  year = {2025},
  doi = {10.1148/rycan.240096}
}
Kostenlos starten →